Trial intelligence / Profile preview

Ketorolac vs Sumatriptan Nasal Spray for Acute Migraine

NCT01807234Phase 4Completed

Sponsor
Johns Hopkins University
Start
Feb 2013
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ketorolac in migraine, sponsored by Johns Hopkins University. Started Feb 2013; status: completed.

02

Drugs

ketorolac
03

Conditions

migraine

Beyond the preview

Go deeper on NCT01807234.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01807234.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call